| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003046 | American Journal of Ophthalmology | 2012 | 7 Pages |
Abstract
Adjunctive subconjunctival bevacizumab with trabeculectomy is effective in controlling the IOP profile; however, its effect is less prominent than that of MMC.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Naveed Nilforushan, Maryam Yadgari, Shahin Khosh Kish, Nariman Nassiri,